연구동향 분석
박사

Healthcare spending and utilization of lung cancer patients using 2002-2012 health insurance claims data

김선정 2015년

논문상세정보
인용/피인용
' Healthcare spending and utilization of lung cancer patients using 2002-2012 health insurance claims data' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • health care utilization
  • healthcare spending
  • lung cancer
  • survival
  • 생존기간
  • 의료비
  • 의료이용
  • 폐암
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
760 0

0.0%

' Healthcare spending and utilization of lung cancer patients using 2002-2012 health insurance claims data' 의 참고문헌

  • Zhao H, Zuo C, Chen S, et al. Nonparametric inference for median costs with censored data. Biometrics 2012; 68(3):717-725.
  • Yoon SJ, Lee H, Shin Y, et al. Estimation of the burden of major cancers in Korea. Journal of Korean Medical Science 2002; 17(5):604- 610.
  • Woods LM, Rachet B and Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Annals of Oncology 2006; 17(1):5-19.
  • Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women? Journal of Clinical Oncology 2007;25 (13):1705-1712.
  • White M, Adams J, Heywood P. How and why do interventions that increase health overall widen inequalities within populations. Social Inequality and Public Health 2009. 65-82.
  • Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA: A Cancer Journal for Clinicians 2008; 58(1):9-31.
  • Wang SJ, Fuller CD, Thomas CR, Jr. Ethnic disparities in conditional survival of patients with non-small cell lung cancer. Journal of Thoracic Oncology 2007;2 (3):180-190.
  • Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncology 2007; 8(9):784-796.
  • Tolle SW, Rosenfeld AG, Tilden VP, et al. Oregon's low in-hospital death rates: what determines where people die and satisfaction with decisions on place of death? Annals of Internal Medicine 1999; 130(8):681-685.
  • Taylor Jr DH. The effect of hospice on Medicare and informal care costs: the US Experience. Journal of Pain and Symptom Management 2009;38(1):110-114.
  • Taylor Jr DH, Ostermann J, Van Houtven CH, et al. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program? Social Science & Medicine 2007;65(7):1466-1478.
  • Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. The Lancet Oncology 2011; 12(10):933- 980.
  • Stevens W, Stevens G, Kolbe J, et al. Lung cancer in New Zealand: patterns of secondary care and implications for survival. Journal of Thoracic Oncology 2007;2 (6):481-493.
  • Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 1995; 13(3):235-252.
  • Slatore CG, Au DH, Gould MK. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. American Journal of Respiratory and Critical Care Medicine 2010; 182(9):1195-1205.
  • Silverstein MD, Nietert PJ, Ye X, et al. Access to care and stage at diagnosis for patients with lung cancer and esophageal cancer: analysis of the Savannah River Region Information System cancer registry data. Southen Medical Journ 2002; 95 (8):900-908.
  • Shin JY, Kim SY, Lee KS, et al. Costs during the first five years following cancer diagnosis in Korea. Asian Pacific Journal of Cancer Prevention 2012; 13(8):3767-3772.
  • Sen B, Blackburn J, Morrisey MA, et al. Did Copayment Changes Reduce Health Service Utilization among CHIP Enrollees? Evidence from Alabama. Health Services Research 2012; 47(4):1603-1620.
  • Scitovsky AA. " The high cost of dying": what do the data show? The Milbank Memorial Fund Quarterly. Health and Society 1984:591-608.
  • Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases 2009; 49(8):1175-1184.
  • Riihimaki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer 2014; 86(1):78-84.
  • Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Annals of Oncology 2002; 13(7):1087-1093.
  • Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. British Journal of Cancer 2010; 103(4):446-453.
  • Potosky AL, Saxman S, Wallace RB, et al. Population variations in the initial treatment of non-small-cell lung cancer. Journal of Clinical Oncology 2004; 22 (16):3261-3268.
  • Park YS, Kim SH, Park SK, et al. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea. Lung Cancer 2010; 68(2):299-304.
  • Park EC. National Cancer Control Policy: theory and practice. Goyang: National Cancer Center, 2010.
  • Park EC, Jang SI. The diagnosis of healthcare policy problems in Korea. Journal of the Korean Medical Association 2012;55(10):932- 939.
  • Park EC and Park JH. Burden of cancer and its reduction strategies in Korea. Seoul: Korea Foundation for Cancer Research, 2013.
  • Organization for Economic Co-operation and Development. OECD health data 2014: how does Korea compare, 2014.
  • Newhouse JP. Consumer-directed health plans and the RAND Health Insurance Experiment. Health Affairs 2004; 23(6):107-113.
  • Natinal Cancer Center. Status of hospice and palliative care nationwide. 2011.
  • NICE. Clinical Guideline 24. Lung Cancer: the diagnosis and treatment of lung cancer. London, NICE, 2005.
  • Morrison RS, Penrod JD, Cassel JB, et al. Cost savings associated with US hospital palliative care consultation programs. Archives of Internal Medicine 2008; 168 (16):1783-1790.
  • Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clinic Proceedings 2008; 83(5): 584?594.
  • Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. Journal of Clinical Oncology 2007; 25(2):180-186.
  • Mechanic R, Coleman K, Dobson A. Teaching hospital costs: implications for academic missions in a competitive market. Journal of American Medical Association 1998; 280(11):1015-1019.
  • McDavid K, Tucker TC, Sloggett A, et al. Cancer survival in Kentucky and health insurance coverage. Archives of Internal Medicine 2003; 163(18):2135-2144.
  • McCall N. Utilization and costs of Medicare services by beneficiaries in their last year of life. Medical Care 1984:329-342.
  • Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. New England Journal of Medicine 1993; 328(15):1092-1096.
  • Lohr KN, Brook RH, Kamberg CJ, et al. Use of medical care in the RAND Health Insurance Experiment: diagnosis-and service-specific analyses in a randomized controlled trial. Medical Care 1986;(8 Suppl):S1-S87.
  • Lim JH, Choi KS, Kim SG, et al. Effects of private health insurance on health care utilization and expenditures in Korean cancer patients: focused on 5 major cancers in one cancer center. Journal of Preventive Medicine and Public Health 2007; 40(4): 329-335.
  • Leibowitz A, Manning WG, Keeler EB, et al. Effect of cost-sharing on the use of medical services by children: interim results from a randomized controlled trial. Pediatrics 1985; 75(5):942-951.
  • Lee-Feldstein A, Feldstein PJ, Buchmueller T, et al. The relationship of HMOs, health insurance, and delivery systems to breast cancer outcomes. Medical Care 2000;38 (7):705-718.
  • Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. Journal of Clinical Oncology 2006; 24(3):413-418.
  • Kwon S. Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage. Health Policy and Planning 2009; 24(1):63-71.
  • Kwok J, Langevin SM, Argiris A, et al. The impact of health insurance status on the survival of patients with head and neck cancer. Cancer 2010;116(2):476-485.
  • Korean Hospital Association. Hospital Management Statistics, 2011.
  • Kogevinas M, Porta M. Socioeconomic differences in cancer survival: a review of the evidence. IARC Scientific Publication 1997; (138):177- 206.
  • Kim SJ, Han KT, Park EC, et al. Copayment policy effects on healthcare spending and utilization by korean lung cancer patients at end of life: a retrospective cohort design 2003-2012. Asian Pacific Journal of Cancer Prevention 2014; 15(13):5265-5270.
  • Kim SG, Hahm MI, Choi KS, et al. The economic burden of cancer in Korea in 2002. European Journal of Cancer Care 2008;17(2):136-144.
  • Jung M. Cancer Control and the Communication Innovation in South Korea: Implications for Cancer Disparities. Asian Pacific Journal of Cancer Prevention 2013; 14(6):3411-3417.
  • Jung KW, Won YJ, Kong HJ, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011. Cancer Research and Treatment 2014; 46(2):109-123.
  • Jung KW, Won YJ, Kong HJ, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010. Cancer Research and Treatment 2013; 45(1):1-14.
  • Jeong HS. Korea’s National Health Insurance?lessons from the past three decades. Health Affairs 2011; 30(1):136-144.
  • Jeon B, Kwon S. Effect of private health insurance on health care utilization in a universal public insurance system: a case of South Korea. Health Policy 2013; 113(1):69-76.
  • Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011; 61(2):69-90.
  • International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization.
  • Hong YS. Past, present and future of hospice in Korea. Journal of the Korean Medical Association 2008; 51(6):509-516.
  • Higginson IJ, Astin P, Imperial SD. Where do cancer patients die? Tenyear trends in the place of death of cancer patients in England. Palliative Medicine 1998; 12(5):353-363.
  • Gye SS. Factors affecting the place of death among the elderly in Korea. Graduate School of Public Health SNU, Seoul, Korea, 2012.
  • Grannemann TW, Brown RS, Pauly MV. Estimating hospital costs: a multiple-output analysis. Journal of Health Economics 1986; 5(2):107- 127.
  • Gardiner C, Brereton L, Frey R, et al. Exploring the financial impact of caring for family members receiving palliative and end-of-life care: A systematic review of the literature. Palliative Medicine 2014; 28(5):375-390.
  • Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. Cancer and Metastasis Reviews 2003; 22(1):39-46.
  • Forrest LF, Adams J, Wareham H, et al. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Medicine 2013; 10(2): e1001376.
  • Flenaugh EL, Henriques-Forsythe MN. Lung cancer disparities in African Americans: health versus health care. Clinics in Chest Medicine 2006; 27(3):431-439.
  • Earle CC, Neumann PJ, Gelber RD, et al. Impact of referral patterns on the use of chemotherapy for lung cancer. Journal of Clinical Onc 2002; 20(7):1786-1792.
  • Donaldson GK. Health care financing reforms: moving into the new millenium. Economics of Health Care Financing: The Visible Hand. Basingstoke: Palgrave Macmillan.2005.
  • Doll R, Hill AB. The mortality of doctors in relation to their smoking habits. British Medical Journal 1954;1(4877):1451.
  • Disparities in cancer care. Journal of Oncology Practice 2006; 2(5):234-239.
  • DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. Journal of Health Economics 2003; 22(2):151-185.
  • Davies E, Higginson IJ, Organization WH. Better palliative care for older people: World Health Organization, Regional Office for Europe Copenhagen, 2004.
  • Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377(9760):127- 138.
  • Cohen J, Houttekier D, Onwuteaka-Philipsen B, et al. Which patients with cancer die at home? A study of six European countries using death certificate data. Journal of Clinical Oncology 2010; 28(13):2267-2273.
  • Cohen J, Bilsen J, Addington-Hall J, et al. Population-based study of dying in hospital in six European countries. Palliative Medicine 2008; 22(6):702-710.
  • Chirikos TN, Roetzheim RG, McCarthy EP, et al. Cost disparities in lung cancer treatment by disability status, sex, and race. Disability Health Journal 2008; 1(2):108-115.
  • Burge F, Lawson B, Johnston G. Trends in the place of death of cancer patients, 1992?1997. Canadian Medical Association Journal 2003; 168(3):265-270.
  • Bruera E, Russell N, Sweeney C, et al. Place of death and its predictors for local patients registered at a comprehensive cancer center. Journal of Clinical Oncology 2002; 20(8):2127-2133.
  • Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care 2002;40(8 Suppl):104-117.
  • Berglund A, Lambe M, Luchtenborg M, et al. Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open 2012; 2(3).
  • Belani CP, Marts S, Schiller J, et al. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 2007; 55(1):15-23.
  • Beccaro M, Costantini M, Rossi PG, et al. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC). Journal of Epidemiology and Community Health 2006;60(5):412-416.
  • Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. New England Journal of Medicine 1999; 341(16):1198-1205.
  • Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. IARC Scientific Publication 1997; (138):377-397.
  • Aarts MJ, Lemmens VE, Louwman MW, et al. Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. European Journal of Cancer 2010; 46(15):2681-2695.
  • ?1. Yoon SJ, Bae SC, Lee SI, et al. Measuring the burden of disease in Korea. Journal of Korean Medical Science 2007; 22(3):518-523.
  • ? 8 0 ?
  • 7 3 -